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Abstract Adherence research has been dominated by attitudinal approaches that isolate
individual statements made in interviews and then assign a ﬁxed attitude to the
individual who made that statement. Despite much sociological research
having raised questions about the notion of ﬁxed attitudes, little research has
theorised the process by which individual utterances about medicine-taking are
produced as a form of resistance to medications within interviews. Using
Goffman’s concept of performance as a starting point, this article offers an
alternative framework for conceptualising adherence presentations when
provided in the form of a rhetorical narrative. Through the presentation of case
material taken from interviews with participants who had not taken prophylactic
asthma medications as prescribed, we develop Goffman’s concept of performance
to theorise the production of adherence talk in two important ways. First,
individual performances can be seen to be shaped by how moral discourses of
illness management transfer across contexts. Second, performances are subject to
inequalities in the resources interactants have access to. An extended deﬁnition of
Goffman’s concept of performance is thus offered, arguing that the ‘meaning’ of
individual performances is produced by a combination of which moral discourses
interactants orientate to and which discourses are used to categorise individuals.
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Introduction
The brown, I mean with, I’ve had two or three or four different doses of the brown one
and I’ve played about with it for a week, for nine months sort of thing, and I’m adamant
that it’s not made any difference. It really hasn’t. Yeah and I did forget to take it and I did
forget to, it was just how and the, this thing about using the two in conjunction. Well, it
just, I just never really accepted it (Murdoch 2010: 113).
When people talk about how they manage illness they display a version of their private
experience to an audience in a public space. For many, such displays involve negotiating
‘appropriate’ use of medication – a discursive space where different moralities of illness
management may be contested and negotiated. Although much research has used interviews
to elicit people’s views and experiences of illness and medications as a means of
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understanding why people do not ‘adhere’ to prescribed treatments, less attention has been
paid to unpicking the process by which such talk is produced. In this article we examine how
discursive contexts shape illness and adherence presentations within research interviews and
how we might treat talk about medicine-taking in understanding how individuals manage
illness on a daily basis.
The prescribing of standardised medications to patients to achieve and maintain disease
control occupies a prominent place in the delivery of modern medical care. However, it is
estimated between a third and half of all medicines prescribed for long term conditions are
not taken as recommended (Nunes et al. 2009). Nearly 200 potential barriers to adherence
have been investigated with little success in predicting adherence to prophylactic medications
(Vermeire et al. 2001).
A large proportion of adherence research since the 1970s has investigated individual
patient characteristics as indicators of adherence including beliefs, personality, gender, age,
sex, marital status, social class, disability and psychosocial factors (Vermeire et al. 2001).
Clinical guidelines on medication adherence place beliefs about medications and medicine in
general as having the greatest inﬂuence on adherence (Nunes et al. 2009). Researchers have
frequently elicited individuals’ beliefs by deploying structured questionnaires (Horne et al.
2002), or interviews (Halm et al. 2006), to construct a direct relationship between the
patient’s belief about their disease and treatment with their adherence behaviour. These
methods embody an essentially individualistic philosophy about the relationship between
talk, social context and individual attitudes, built on the principles of social cognition models
(SCMs) (Christensen 2004).The assumption behind SCMs is that the contribution of social
context can account for any contingent deviation from the theoretical expectation that an
individual attitude will determine medicine-taking. This means that any medicine-taking
action which does not logically follow from an individual’s attitude is therefore to be
explained by modifying contextual variables, such as a newspaper article or a conversation
with a friend. The key theoretical link between individual perception and adherence therefore
remains intact. Talk within interviews is typically viewed as an accurate articulation of
individual attitudes, isolated from the context of production, and similarly functioning to
uphold the existence of the ﬁxed individual attitude. By presupposing that individuals have
ﬁxed attitudes, the tools and data produced solipsistically substantiate the existence of such
attitudes.
A range of literature has created difﬁculties for attempts to reduce decisions about
medication to individual characteristics, examining how people negotiate medicine-taking in
competing social spaces, such as in HIV (McCoy 2009), diabetes (Peyrot et al. 1987), arthritis
(Arluke 1980), and asthma (Adams et al. 1997). People may choose not to take medication in
order to assert control over their condition (Conrad 1985); because medications are too
disruptive to lifestyles (Hunt et al. 1989); or as a means of asserting control in patient-
provider relationships (Hayes-Bautista 1976).
This work highlights the importance of attending to the inﬂuence of relationships on
medicine-taking and indicates the role of talk about illness management as a negotiation of
these relationships. Examples of how these negotiations shape discussions about medicines
have been examined in detail in the patient-provider relationship. Clinicians can be seen to
contribute to patients being categorised as ‘compliant’ (Lutfey 2004) through ongoing
interactions; patients have shown divergence in accounts about medicine-use given in and
outside surgery (Britten 1996); may have unvoiced agendas in consultations (Barry et al.
2000); and may resist treatment decisions (Stivers 2006), and questions about medicine use
(Salter 2010). While much of this research has analysed nuanced interactive dynamics of
medication resistance, little is known about the process by which resistance to medicine-
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taking is constructed in an extended rhetorical narrative. This understanding is needed in a
context where researchers deploy the concepts of SCMs as a rationale for decontextualising
such talk into sets of isolated attitudinal statements about medications and illness. This
article seeks to begin this process by offering a conceptual framework for making sense of
face-to-face talk about medications and illness management. Beginning with Goffman’s
(1959) concept of ‘performance’ this article theorises how resistance to medicine-taking is
constructed when people talk to researchers. Here we examine how viewing such talk as
performance may have important implications for conceptualising what is happening when
people discuss their illness and medications. We consider why and how patients offer
information about illness and medications and also how clinicians may (and perhaps should)
interpret and better understand patients through their talk to assist them in making shared
treatment decisions.
Goffman’s concept of performance
Goffman addressed the problem of how individuals go about establishing and maintaining
their individual appearance within everyday life. Goffman argued for face-to-face
interactions to be treated as a domain of analysis in their own right, so providing a means to
compare different kinds of face-to-face interactions as a form of social order, situated in time
and space. He argued that people project social roles in staged performances and he used this
theatrical metaphor to explain a wide range of interactions. Goffman’s unique dramatisation
of everyday face-to-face encounters directed attention to the intricate and contingent
functions of impression management and problems people often have in conveying their
intended version of themselves and their role within speciﬁc face-to-face interactional
dynamics. Goffman deﬁned performance as:
All the activity of a given participant on a given occasion which serves to inﬂuence in any
way any of the other participants (1959: 26).
Goffman situated the performance of roles in a moral context, socially binding the performer
and the co-participants by a sense of shared moral obligation to accept and treat the
performance as ‘real’. What people ‘ought’ (Goffman 1959: 24) to see in a performance is
therefore key to the ongoing interaction. Goffman offered a framework for seeing
performances as situated within a particular interactional order which has links with
Bourdieu’s later concept of ‘habitus’ to explain socially recognisable behaviour. However in
Goffman’s (1983: 11) later work, he argued for a relationship between social structure and
individual expression which, rather than being unidirectional and deterministic, constituted a
‘loose coupling’. From this stance interactional displays do not reproduce exact copies of
idealised normative behaviour but produce loosely recognisable versions of culturally
understood behaviour appropriate for speciﬁc social roles. In such cases the performance the
‘audience’ sees should be interpreted in relation to those culturally-understood social roles
being activated within the interaction taking place. Individual utterances may therefore be
similarly understood as manifesting a loose coupling between cultural discourse and the
idiosyncrasies of particular interactions.
Drawing on Goffman’s framework of interactional behaviour we can talk about medicine-
taking as a performance which will be situated spatially, historically and morally, enabling
examination of its functions within an interactional dynamic with particular pertinence for
understanding peoples’ actual medicine-taking.
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Talk about health and illness as social and moral action
Seeing health and illness talk as social and moral action has been highlighted in a range
of disease speciﬁc literature such as AIDS and drug use (Hassin 1994); chronic pain
(Werner et al. 2004); and treatment decisions for cancer (Bishop and Yardley 2004).
People may make choices about taking medicines to avoid stigma and maintain social
relationships (Conrad 1985); and may spontaneously avoid disclosing illness within
interactions to keep illness understated in a relationship (Charmaz 1991). Radley (1993)
argued illness experience entails an individual, not just meeting speciﬁc physical
requirements to participate in society, but also arranging details of their lives to avoid
stigmatisation. Health-related actions and their presentation therefore need to be
legitimised, if the individual is to avoid moral condemnation (Broom and Whittaker 2004)
and to achieve a status that does not separate them from cultural conceptions of a
‘normal’ health status.
Goffman’s notion of performance is reﬂected in studies demonstrating performance of
illness in everyday life (Bury 1988, Faircloth 1999), and has been used to understand
how people provide illness narratives in clinical settings, referred to by Mattingly (2004:
73–94) as ‘healing dramas’. Riessman (2003a, 2003b) used the theories of Bourdieu and
Goffman to examine two contrasting performances of masculinity, situating these
accounts within an interactional context in which the social structures of gender, class
and disability could be seen to structure, and be reinvented in, accounts of the body and
social space.
The objective of the study in this article was to examine the discursive construction of
asthma management, for people previously reporting they had not taken asthma
prophylactic medication as prescribed. Individual culpability for causes and display of
asthma, have been shown as linked and circulated in a variety of linguistic contexts through
history (Murdoch 2010). How people construct talk about prophylactic medicine-taking as a
moral concern is particularly pertinent because such talk is frequently used by researchers
and clinicians to assess and improve how people ‘adhere’ to medications over a long period
of time.
Methods
This study was carried out as the qualitative component of a large randomised controlled
trial, ELEVATE (Price et al. 2011). ELEVATE compared clinical and cost effectiveness of
different asthma medications and showed that for some people with asthma, a prophylactic
medicine (leukotriene receptor antagonist) may be as effective as usual inhaled steroids. The
qualitative component was to elicit the experiences and perspectives of participants,
prescribed prophylactic medications as part of ELEVATE, and to examine the production of
talk about their condition and medications.
Participants and setting
Twenty-six out of a total 306 participants were recruited for the qualitative study. ELEVATE
participants had been prescribed a prophylactic asthma medication – either an inhaled
steroid or a tablet prophylaxis – and were clinically assessed as having inadequate asthma
control and quality of life, measured by a combination of breathing tests and questionnaires.
The focus of this sub-study was on those participants with a record of ‘previous non-
adherence’ as opposed to newly prescribed. Fifty-four ELEVATE participants were identiﬁed
as potentially ‘non-adherent’ to the prophylactic medications based on analysis of
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prescription records and their self-reported non-adherence to previously prescribed inhaled
steroids. Twenty-four of these 54 participants agreed to be interviewed. We recruited two
further participants who had not taken asthma prophylactic medications before entering the
study.
All participants were white British, lived in Norfolk, Suffolk and Cambridgeshire and
spoke English as a ﬁrst language. The range of participant demographic characteristics
closely matched the broader sample in the main trial in terms of: age (between 17 and
80 years, average 49 years (main trial = 46 years); gender (13 (50%) were women; main
trial = 51%); and time since diagnosis (between 1 and 40 years, average 12 years; main
trial = 13 years). Participants for the qualitative study also offered diversity in terms of
occupation, reported as: farmer, farm manager, school pupil, retired general practitioner,
social services employee, telephone engineer, health visitor, caterer, housewife, cleaner, car
showroom manager, retired, trainee school teacher, and pub landlord.
Ethical considerations
ELEVATE was approved by the Eastern Multi Centre Research ethics committee and local
ethics and research governance committees. Participants were invited to take part in the
qualitative component concurrently with ELEVATE during 2004–2005. When contacting
participants the researcher informed them the aim was to understand their views and
decisions about asthma and medications, as well as views of health and illness in general.
Signed informed consent was given by each participant.
The study design
Face-to-face interviews were undertaken with 26 participants to examine how they described
their asthma and explained their medicine-taking. Mason’s (2002: 68–74) guide to structuring
qualitative interviews was used to construct an interview schedule and a series of ‘topic cards’
to guide the discussion. These included: ‘biography of asthma’, ‘treatments’, ‘relationships
and asthma’ and ‘risk and severity’, helping the interviewer elicit a mixture of narratives and
‘attitudes’ from interviewees. Interviews lasted approximately one hour, ranging from
30 minutes to 105 minutes.
Analysis
In the initial analysis, audio tapes of all interviews were listened to, to identify the different
ways participants justiﬁed their medicine-taking, and ﬁve different ‘accounting styles’ were
then assigned to participants’ explanations. However, when we examined the interview
transcripts we discovered that participants’ explanations varied to such an extent that our
initial categorisations could be seen to gloss over this complexity. To resolve these problems
we therefore analysed transcripts, using concepts drawn from discursive psychology (DP)
(Potter and Wetherell 1987), and linguistic ethnography (Rampton et al. 2004), to identify
how the 26 participants constructed versions of their asthma management and medicine-
taking, potentially using a range of rhetorical devices to legitimate their actions. A key
aspect of DP analysis is not only how speakers present themselves and versions of events
but also how they can be seen to undermine competing, less desirable, alternative
interpretations. Transcripts were therefore analysed to identify all instances of participants
orientating to competing versions of illness management and how these versions varied
throughout the interview. Evidencing these devices enables insight into how people may not
simply report information about their beliefs about illness or medication but instead
orientate to issues of blame and accountability activated within the interactions taking
place.
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Findings
Twenty three of the 26 participants interviewed employed a range of rhetorical devices to
justify their medicine-taking, while three participants offered little justiﬁcation for their
behaviours. Participants’ justiﬁcations could be seen to activate multiple moral discourses
of illness management which were used in different ways to perform different interactional
tasks. By identifying what is different and shared in these interactional sequences we were
able to examine the relationship between discourses of morality and individual utterances.
Demonstrating the moral structuring of participants’ talk in this way highlights how talk
about asthma management can be theorised as performance rather than an accurate
articulation of an individual’s attitudes about health, illness or medication. However, our
aim was not to organise our data into a complete set of ways in which participants
justiﬁed medicine-taking. While many participants provided similar explanations for not
taking the medications, within our discursive analytical framework, assigning a single
thematic category to each participant would have been both illogical and not possible, as
participants could be seen to deploy diverse, and sometimes contradictory, explanations
within the same interview. Rather, we aimed to identify how participants’ talk was
produced.
Our level of analysis in this study was therefore language, not individuals, and our means
of generalising ﬁndings the manifestation and circulation of language in different social
spaces. Birdwhistell (Varenne and McDermott 1998) provides a useful analogy to illustrate
such an approach. Individuals, viewed as threads of a rope, are discrete, discontinuous
objects, which also contribute to the twisted continuity of the rope, so that statements about
individual threads (attitudes, experiences, expectations) can also be viewed as statements
which demonstrate how threads and rope are linked (social structure, power, connectivity of
language). In our study, if different participants with distinct ways of talking about medicine-
taking could be seen to orientate to similar moral discourses of illness management this could
provide the threads linking individual utterances to the rope of social structure; what
Goffman referred to as ‘loose coupling’.
The ﬁve extracts presented here have been selected as representing distinct ways in which
participants justiﬁed their medicine-taking. Our focus on these few cases permits readers to
develop a sense of the complexity of adherence presentation in the context of research
interviews, enabling an alternative conceptual framework to be offered to that held within the
SCM philosophy. Despite displaying different versions of asthma management, these
participants can be seen to display distinct similarities in the moral discourses of medicine-
taking they deployed and activated within those interactions. The cases presented here are
therefore not intended to be viewed as the set of ways in which the participants in our study
talked about medicine-taking, but instead offer a diverse set of cases whose use might help in
ﬁnding a perspective from which to examine the structuring of talk about medicine-taking.
Minimising asthma and symptom control in an everyday context
A commonly-identiﬁed explanation for not taking asthma medications involves people
minimising the impact of asthma on everyday life (Protudjer et al. 2009). Such explanations
were also common with many of this study’s participants and Extract 1 presents such an
example. However, when viewing this talk as a rhetorical performance, we can see potential
implications of this strategy in everyday settings. Martin, a 56-year-old farm manager,
diagnosed with asthma in his 40s, deploys a strong stylistic assertion to minimise his
condition in the opening line.
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Extract 1: Martin
1. Martin: So I have it has been. But I stress it is not a debilitating problem insofar as my
2. y’know my work is concerned or my you know my life is concerned. Um I
3. don’t play football I do occasionally bouts of strenuous work um but it’s
4. managed and I’m very fortunate in that you know I can choose (in the middle
5. of something?) what what I do at work rather than um you know being in a
6. managerial position I mean I don’t wanna y’know er brag but you do have a
7. little bit of ﬂexibility um and if there’s you know y’know there’s somebody
8. else available who will move the grain lorry up and you know I would do his
9. job while he did while he did that and if it’s unavoidable well I I’ll do you
10. know put a mask on and move the lorry myself which is it’s not an issue as far
11. as I’m concerned you know the guy um you know I can certainly ask
12. somebody else can you just move down while I take over from you everybody
13. knows that the reason I’m doing it I’m not frightened of work but they just I
14. can manage it in that way um so I suppose you could say well actually you are
15. changing your lifestyle but not to that degree.
Analysing the rhetorical work in this extract showsMartin deploying several devices to provide
evidence for his claim that his asthmawas not debilitating and he was responsiblymanaging his
condition. He illustrates his control of his asthma by detailing a common scenario at work; a
ﬂexible situation that was agreed and understood by his colleagues and was afforded by his
managerial position. Alongwith a list of other activities where his asthmawas being ‘managed’,
Martin provided a catalogue of evidence to support the case that ‘it is not a debilitating
problem’ (line 1). However, as a consequence of scripting a typical work scenario to
demonstrate this position,Martin could be seen to negotiate a number of positions or ‘footings’
(Goffman 1981), activated by using this scripting device and which threatened an alternative
interpretation of his behaviour. This is evidenced in the interactional repair work Martin
displays. First he orientates to a potential interpretation that suggests that the adaptive
strategies he uses atwork show someone struggling to copewithworkactivities, ‘it’s not an issue
as far as I’m concerned’ (lines 10–11), then that he was exploiting his employees, ‘everybody
knows that the reason I’m doing it’ (lines 12–13), and that he was lazy or workshy, ‘I’m not
frightened of work but they just’ (line 13).We can seeMartin was simultaneously attempting to
construct different versions of his self which included ‘responsible person with asthma’, ‘person
with health problem that is not an illness’, ‘conscientious worker’, and ‘goodmanager’. Finally,
Martin’s assertion that his lifestyle had not changed ‘to that degree’ offers further evidence of a
key issue at stake in this discussion of asthmaprevention.Whether his lifestyle had changedwas
not a question put to him. So it seems reasonable to infer that he was responding to the framing
of this interactional sequence within competing moral discourses of appropriate and
responsible illness management, while also responding to different moral discourses from his
everyday life, deﬁningwhat itmeans tobe a goodmanager and a hardworker.
Martin’s presentation of a ‘responsible person with asthma’ does not appear to ﬁt neatly
with Martin’s ‘responsible manager’ discourse, appearing to potentially risk positioning
himself as a manager who exploits members of his workforce for his own ends. This is a
rhetorical cul de sac for Martin, as he becomes reliant on the listener to provide any
discursive space for this tension to pass without confrontation. Martin could be seen to
orientate to and actively manage this tension thereby validating the importance of these
different moral frameworks within the interaction taking place. This insight into the moral
dimensions of Martin’s talk demonstrates that an approach which reduces Martin’s talk to
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an attitudinal statement, that he viewed his asthma as ‘not debilitating’, would miss
important insights into how Martin’s asthma management is inﬂuenced by what asthma and
illness mean as activities, set alongside other socially-situated activities in his working
environment. Martin’s decisions appear to be inﬂuenced at least as much, by his
preoccupation with being seen as a good manager; a good worker; and as someone who does
not have an illness; alongside simply taking a view of his asthma as not being serious enough
to warrant regular prophylactic treatment.
Deploying a sick-role discourse to blame healthcare
In contrast to explanations such as those seen in Martin’s extracts, several participants
justiﬁed their medicine-taking by blaming clinicians or healthcare generally. The next extracts
are taken from an interview with Irene (pseudonym), a 63-year-old retired woman with a
complicated medical history, diagnosed with asthma 15 years previously, who explained why
she had not attended her local surgery. Irene was prescribed asthma prophylactic tablets and
argued that she stopped because she thought they made little difference. The following two
extracts were chosen to typify a pattern whereby Irene situated her health problems within
the context of an untrustworthy, uncaring medical profession, yet presented through
rhetorical devices which served to rationalise her criticisms.
Extract 2: Irene
1. Jamie: What don’t you like about the tablets?
2. Irene: I think you keep ﬁlling your body up with all these tablets and you know, I
3. don’t know I just feel that, is that causing my problem, you see with my
4. problem my stomach problem I just, I (??) with my stomach, em, I feel
5. everything I eat I get pain in here I ain’t been to the doctors with it yet. Sort of
6. there like, I don’t know if I got an ulcer or what and I, I think tablets you
7. know, I don’t know it might be me, I ain’t really a big fan of tablets.
8. You see but I have been taking them for years coproximol and I’m saying
9. years, no they’re now telling you that they’re bad. They going to take them off
10. the shelf, don’t know if you saw the article?
Here, Irene expresses a general concern about tablets which serve to contextualise the
decisions about the asthma tablet. She does this by deploying a metaphor, ‘ﬁll up’, to directly
challenge the value of taking an aggregated category ‘tablets’. The idea of the body as a
container which can be ﬁlled up stresses the argument that adherence means her body cannot
keep any more tablets in, spilling over with medication. She blends the mitigating phrases
‘I don’t know I just feel that’ and ‘I don’t know it might be me’ with a personal narrative of
her long experience with tablets and stomach problems to present her criticism of tablets. The
sense of apprehension emphasised with a lack of cohesion in the sentence ‘I just, I (??) with
my stomach, em, I feel everything I eat I get pain…’ suggests an uncertainty in presenting this
position, yet her arguments are supported and therefore normalised with reference to a press
article as evidence ‘they’re now telling you that they’re bad’. By using the collective term
‘they’ to refer to science and medicine, Irene might be justifying not taking the asthma tablet
by associating it with and undermining the solidity of medical knowledge regarding another
tablet. Her behaviour can thus be accepted as reasonable because if medical knowledge about
medications changes then it cannot be trusted, raising questions for taking them. Her earlier
statement that she ‘just sort of left it’, can now be understood as acceptable and frees her
8 Jamie Murdoch et al.
 2012 The Authors
Sociology of Health & Illness  2012 Foundation for the Sociology of Health & Illness/Blackwell Publishing Ltd
from blame. As this interaction continued, Irene’s position on medications was set within
dissatisfaction with healthcare more generally and similar rhetorical devices were used to
account for her nonattendance at her local surgery.
Extract 3: Irene
1. Jamie: So you’ve been, how many times have you been back in to the
2. surgery in the last year for your asthma?
3. Irene: I’m a, you see this is the thing I should see an asthma nurse but thing is
4. the only time my asthma’s ever mentioned down that surgery is if I had, like
5. when I had bronchitis, ‘ooh, you got asthma eh, take more inhaler’ you know,
6. ‘do more inhaler’ but apart from that there’s no em, request to see the asthma
7. nurse or anything like that and as far as I’ll be honest with you I do ﬁnd in
8. today’s world and I’m not alone we got one of the best surgeries I think down
9. there, I really do but, they still like say you went down with a complaint
10. and you got two or three other things on your mind, they don’t want to hear,
11. you got to make another appointment all the time. For the specialised thing,
12. whatever you want and invariably I think they don’t really you know, want to
13. know really to be honest.
Here the interviewer’s (Jamie’s) question appeared to represent a face-threatening act
which Irene could be seen to orientate towards. The issue appeared to be potential
criticism that she was not taking responsibility for her asthma because she had not
attended the surgery as she should. This is evidenced with the use of the modal verb
‘should’ (line 3). However, this was merely a preface to direct criticism of the quality of
care that she received, namely that the surgery did not take enough interest in her asthma,
‘the only time my asthma’s ever mentioned down that surgery’ and that ‘they don’t really
you know, want to know really to be honest’ (lines 12–13). Here Irene constructed a very
clear picture of herself – as a patient with concerns she wanted to discuss, and ‘that
surgery’ – as dismissive of these concerns, lacking interest in her individual circumstances.
These versions were not merely described, but were authenticated using a range of
rhetorical devices. First, she provided a speciﬁc example of a typical response to her
expressions of concern, adopting the voice of doctors and nurses in an ironic tone ‘ooh,
you got asthma eh, take more inhaler’ you know, ‘do more inhaler’ (line 6). This was
followed by a normalisation device positioning her uncaring surgery as pervasive of the
NHS more generally and representative of an uncaring world. Moreover she used the
evidence of allies ‘I do ﬁnd in today’s world, and I’m not alone’ (lines 7–8). This served to
rationalise her stance by erasing any notion that this view was radical or irrational. She
added weight to her argument by twice revealing she was conﬁding in the interviewer –
‘I’ll be honest with you … to be honest’. This represents a truth claim which has been
thought through and which she has amassed evidence to support. Irene also set these
criticisms within a mitigating phrase which served to position her criticisms as reasonable,
‘we got one of the best surgeries I think down there, I really do’ (lines 8–9).
These extracts were indicative of how Irene could be seen to manage issues of blame
and accountability for her decisions and views about medications and healthcare
generally. Thus a moral discourse of illness management and health behaviour appeared
to be activated within the interaction in allocating blame for her symptoms and
decisions about medicine-taking. We are left in no doubt that Irene made a particular
connection between the provision of health and a particular moral expectation. Further,
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she set up a moral connection between those who provide healthcare, how that
care should be delivered, and the motivations and characteristics of those doing the
caring.
It may be interpreted, drawing on Parsonian theory (1951), that Irene was deploying a
‘sick-role’ discourse where the sick person is exempted from normal social responsibilities,
not blamed for being sick, expected to seek competent help in the form of a doctor and
to comply with a prescribed regimen. Irene’s explanation was not a precise version of
Parsons’ concept but drew on this model of the doctor-patient relationship to construct a
version which tackled the particular issues at stake within the interaction. These appeared
to orientate around whether Irene was justiﬁed in not attending her surgery more
frequently and not taking prophylactic asthma medication. Irene’s version of the sick-role
included criteria for a competent physician – somebody who attends to the patient’s
individual circumstances, ‘the specialised thing’ (line 11) and proactive in managing the
patient’s asthma (lines 6–7). In deploying a visual metaphor of the individual passively
ﬁlling up and spilling over with tablets (Extract 2, line 2), Irene also activated a culturally-
available conceptualisation of the sick individual with a range of unspeciﬁed symptoms
and vague causes which the tablets were producing rather than solving. Irene’s rhetoric
rested on arguing that doctors, nurses and the institution of medicine had not met the
conditions of competent physician and reliable treatment regimen. In this sense, the
institution of medicine can be said to have violated the sick-role contract that Irene had
set up. Thus Irene was able to justify not only her non-attendance but also her decision to
not take the asthma tablet and position this as virtuous and preventive rather than
causative of illness.
Deploying a sick-role discourse for self blame
Irene explained her health problems by directing blame towards the dangers of medications
and uncertainty in medical knowledge as well as directly questioning the motivations of
clinicians themselves. By contrast, Stephen, aged 31, self-employed with asthma since
childhood, was the only participant of the 26 interviewed who repeatedly blamed himself for
his asthma problems.
Stephen was asked how he saw the future in terms of his asthma and to reﬂect on his
experiences with doctors and nurses. Here we demonstrate how Stephen directly positioned
himself as a bad patient within a moral framework of a sick-role discourse.
Extract 4: Stephen
1. Stephen: I don’t have any complaints over my treatment of doctors or
2. asthma nurses over the last few years. I think basically they’ve been
3. banging their head against a brick wall with me over the years.
Stephen used a common metaphor, banging one’s head against a brick wall, to describe
doctors’ and nurses’ actions. This positioned clinicians as persistent, well-intentioned and
importantly active in doing the ‘banging’. In contrast, Stephen constructed himself as the
wall – a ﬁxed, immovable object. Having ‘no complaints’, set this metaphor within a moral
discourse of roles and responsibilities which clinicians fulﬁlled. Like Irene, Stephen deployed
a discourse which set up a sick-role contract between him and clinicians. How Stephen
positioned himself within this moral contract, however, is interesting and in Extract 5, in
contrast to Irene, it was Stephen who violated the sick-role contract.
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Extract 5: Stephen
1. Stephen: I’m just sort of glad to be part of this study and in a way feel guilty on my part
2. over the years of not being very helpful or cooperative or whatever hhh and I
3. just think well if I’ve got a chance to be part of one of 700 people in the
4. country that are doing this to try and battle against asthma then I’ll do
5. anything that I can to, to try and help really. And if you know, it’s opened up a
6. big can of worms and it’s brought everything to my mind and it’s quite
7. upsetting you know at times, talking about how you feel and how it
8. makes you feel psychologically as well.
Stephen not only admitted guilt but displayed remorse for his behaviour and offered a
commitment to become a better person given a chance. These notions of guilt,
cooperation and having chances, reproduced a rehabilitation discourse set within
dominant medical discourses of remission (Frank 1995), and also cultural probationary
discourse of criminals (Proeve et al. 1999). Stephen’s justiﬁcation of non-adherence
involved constructing himself at a crossroads in his life. Within his talk, Stephen could be
seen morally to be taking the right road at this crossroads. While his previous behaviour
was positioned as uncooperative and a violation of a sick-role contract, the commitment
to change functioned interactively to present himself as on a different road, to be a
purposeful and rehabilitated patient.
Similar to Irene, Stephen drew on traditional ideas of the doctor-patient relationship and
constructed versions of himself, doctors and nurses in explaining his non-adherence to
medications. However, unlike Irene, Stephen undertook little rhetorical work to discredit
potential alternative interpretations of his actions. This may be because he blamed himself for
his non-adherence and positioned his explanation within broader discourses of remission,
rehabilitation and remorse. Blaming oneself and not doctors could be seen as a submissive
and compliant position within traditional doctor-patient conceptualisations. This discursive
action does not challenge a powerful institutionalised set of roles and relationships but
instead reproduces a widely understood discursive object, the ‘bad patient’ within this
common discourse. In addition, in British society an explanation of self-blame and remorse is
typically viewed as ‘honest’ when activated within rehabilitation discourse. There was
therefore little need for Stephen to provide supporting evidence for the version being
constructed. Alternatively, Stephen may have attempted to save ‘face’ by criticising himself,
enabling him to ‘own’ any judgement of his behaviour, rather than potentially having it
directed at him through the ongoing discussion. Stephen’s ‘owning’ of the criticism may
therefore have limited the need for Stephen to justify his asthma management any further.
This contrast between how Stephen and Irene deployed these discourses provides an
important point of triangulation between the justiﬁcations, strengthening the interpretation
that moral discourses were structuring participants’ talk. The construction of the ‘bad
patient’ within Stephen’s sick-role discourse (requiring little rhetorical work and supporting
evidence), and the ‘bad doctor’ within Irene’s account (requiring a lot of rhetorical work and
supporting evidence), highlighted the moral value attributed to being a compliant patient
within a medical discourse regarding clinical advice and prescription instructions. The
contrast between the interviews of Irene and Stephen thus provides further evidence that a
moral discourse of illness management was activated within participants’ talk which included
traditional notions of compliance to doctors’ instructions.
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Study limitations
Being asked to provide a long narrative about one’s asthma was an unusual occurrence for
many participants in this study. The interviews, while well deﬁned from an academic
perspective, may have had vague boundaries and deﬁnitions for participants. Thus it is
conceivable that those who justiﬁed their medicine-taking may have responded to particular
interactional conditions activated within individual interviews. These encouraged an
individualising discourse within research which had recruited participants based on their
asthma being categorised as inadequately controlled and those patients being potentially
blameworthy for that inadequate control. For many participants, being interviewed about
their decisions was likely to activate issues of blame and accountability. This raised
uncertainties for the authors regarding how far claims about the role of morality in talk could
extend beyond these circumstances to other types of interaction about medicine-taking. Such
uncertainties posed a requirement to identify data that could be considered ‘new’ and this
evidence has been discussed elsewhere (Murdoch et al. 2010).
Discussion
This study identiﬁes difﬁculties in interpreting talk about medicine-taking as accurately
representing an individual’s management, attitudes or beliefs about illness. A process of
analysis which isolates talk into sets of de-contextualised statements risks categorising that
talk in ways which mask its function within the interaction of its production. Alternatively,
by viewing such talk as continuously constructed performances, loosely structured by moral
discourses, we can then see reported individual statements working interdependently in
constructing presentations of self and behaviour. These ‘presentations of self’, crucially, may
orientate to different concerns and may be more about how people wish to be understood
according to different moral issues activated within those interactions. This point has been
made by Williams (1993), who argued that terms such as ‘adaptation’, ‘adjustment’, ‘coping’,
when applied to how people live with chronic illness, are based on a world of contingency.
These are categorisations of actions according to potential adverse outcomes, for example, an
asthma attack. Williams argued that these categorisations fail to account for peoples’ talk
about their illness not orientating to these contingencies. People with chronic illness, he
argues, are not trying to display an optimum management strategy, rather how they wish to
be understood according to differing moral dimensions that inform their lives. The discursive
psychological analysis of the face-to-face interviews conducted in this study highlights
Williams’ point, with speakers seen to deploy complex rhetorical devices to construct
particular versions of self and behaviour and to undermine less desirable alternatives.
The complexity identiﬁed in participants’ talk reveals the intricate dimensions of
impression management that Goffman referred to and also the dynamic relationship between
individual utterance and social structure. Participants activated culturally understood
discourses, by presenting their versions of their asthma management as plausible to meet the
interactional tasks of ensuring their performances functioned effectively. The same moral
discourses of illness management were seen in very different explanations, suggesting their
circulation to different social spaces for different interactional functions. However, analysis
showed that participants did not deploy replicas of these discourses but actively constructed
their own versions to meet speciﬁc interactional demands on them to justify their medicine-
taking. This loose coupling between social discourse and talk indicated how notions of
morality, illness management and medicine-taking may circulate a wide range of social spaces
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which structure talk in interactions about medicine-taking and which may be used creatively
to meet a range of interactional concerns.
Although Goffman examined what was unique and shared between face-to-face
encounters, in this study, identifying evidence of the circulation of discourse extended the
boundaries of Goffman’s conceptualisation of performance beyond the immediate
interactional context. Participants could be seen to orientate simultaneously both to medical
and also to other cultural discourses of illness management, indicating performances not
bounded by the face-to-face interaction but orientating to discourses pertinent to their
everyday lives. Talk about medicine-taking is therefore organised not just by the ongoing
interaction (as often argued in conversation analysis of clinical interactions) but is structured
by discourse that circulates across social spaces. In clinical interactions these discourses may
be visible or invisible within the talk taking place, while in this analysis of narrative become
more explicit in the speaker’s rhetorical construction of their illness management.
Additionally, participants’ versions of illness management were subject to the resources
available to them and those which they felt relevant within the interaction taking place. This
highlights the potential for performances to be judged differently, depending upon with
whom, about what, and where the interaction is taking place. From a medical perspective,
that commonly deploys a discourse of adherence in framing patients with asthma, it is
possible to argue that Martin’s and Irene’s explanation of their asthma management should
be interpreted very differently. Martin may be seen as much more ‘fully engaged’ with his
asthma, using various self-monitoring strategies which therefore justiﬁed his not taking
prophylactic medication. In contrast, Irene may be judged to have ‘incorrect’ or ‘irrational’
beliefs. However, as Martin and Irene can each be seen orienting to very different moral
concerns, we have no way of knowing whether Martin is actually more engaged with his
asthma. Thus, rather than individuals’ attitudes towards medication and illness being elicited
and categorised within interactions about illness management, it is an individual’s linguistic
performance that may be categorised by the researcher, doctor, nurse, according to the
criteria set up within that interaction.
Performing different social roles, in key interactional contexts, can enable access to
particular types of outcomes regarding the clinical management of symptoms or enabling
participation in activities within everyday settings such as work. Understanding how talk
about medicine-taking operates as a performance therefore provides insight into interactional
processes by which people living with chronic illness might come to be categorised, the
relevance of these categorisations and their consequences for treatment decisions. Within
clinical discourses of illness management, patients may become designated as ‘good patients’,
‘bad patients’, ‘responsible’, ‘irresponsible’, as having ‘accurate understanding’ or ‘incorrect
beliefs’, as ‘compliant’ or ‘non-compliant’. Such discourse-related categorisations may be
based on clinical judgements of the effectiveness of their talk within an interaction according
to particular criteria of disease control and associated recommendations for appropriate
management. Peoples’ performance of that talk may affect how they are assigned within that
framework and consequently to the treatment decisions reached by clinicians ultimately
resulting in patients potentially being prescribed unwanted medications.
If conceptualisations of patients’ talk require its re-location within a performative context,
so too do notions of ‘evidence’ and of patient and clinical ‘expertise’ in reaching treatment
decisions. Such evidence, provided by the patient, instead of focusing only on their talk as a
means of assessing the accuracy of patient’s beliefs, could also be read as indicating the
dilemmas and issues at stake when negotiating competing moral concerns. The need to
facilitate discussion of patient’s concerns about medications has already been highlighted in
research that has shown the difﬁculties patients experience in articulating such concerns
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(Barry et al. 2000). Taking this stance, the clinician’s role as expert would therefore be less
about advising patients on what they ‘should’ be doing but rather offering a treatment that
meets the patient’s concerns and needs. This is not to say that patients become ‘empowered
decision-makers’ or that clinical consultations should be an arena where decisions are
necessarily shared. Despite ideological shifts towards conceptualising consultations as being
‘patient-centred’, some patients actively defer to medical expertise in reaching treatment
decisions (Pilnick and Dingwall 2011). Rather, discussions about illness management could
be repositioned so that decisions are more fully informed by issues pertinent to patients in
everyday life. Thus patient expertise does not lie in providing the treatment solution, but in
their experience of issues affecting their participation in everyday activities.
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